Edition:
United Kingdom

ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

69.43USD
8 Dec 2017
Change (% chg)

$2.14 (+3.18%)
Prev Close
$67.29
Open
$67.83
Day's High
$69.69
Day's Low
$67.83
Volume
42,332
Avg. Vol
54,428
52-wk High
$74.63
52-wk Low
$42.26

Select another date:

Thu, Nov 2 2017

BRIEF-ANI Pharmaceuticals Q3 gaap earnings per share $0.40

* ANI Pharmaceuticals reports record third quarter and year-to-date 2017 results and narrows full year guidance

BRIEF-ANI Pharmaceuticals announces launch of Oxycodone Hydrochloride oral solution

* ANI Pharmaceuticals Inc announces approval and launch of Oxycodone Hydrochloride oral solution, 100 mg/5ml

BRIEF-Ani pharmaceuticals reports Q2 adj. earnings of $0.98/shr

* Ani Pharmaceuticals reports record second quarter and year-to-date 2017 results and reaffirms guidance

BRIEF-ANI Pharmaceuticals announced launch of diphenoxylate hcl and atropine sulfate tablets

* Ani Pharmaceuticals Inc - announced launch of diphenoxylate hcl and atropine sulfate tablets, 2.5mg/0.025mg Source text for Eikon: Further company coverage:

BRIEF-ANI Pharmaceuticals files for mixed shelf of up to $350.0 million

* Files for mixed shelf of up to $350.0 million Source text: (http://bit.ly/2rokUdK) Further company coverage:

Select another date: